SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15746056
Source:
http://linkedlifedata.com/resource/pubmed/id/15746056
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0056154
,
umls-concept:C0079083
,
umls-concept:C0920321
pubmed:issue
4
pubmed:dateCreated
2005-3-4
pubmed:abstractText
Preclinical evidence of synergy led to a phase I trial employing combretastatin A-4 phosphate (CA4P), a novel tubulin-binding antivascular drug, in combination with carboplatin.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9502500
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Stilbenes
,
http://linkedlifedata.com/resource/pubmed/chemical/combretastatin A-4
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1078-0432
pubmed:author
pubmed-author:BilenkerJoshua HJH
,
pubmed-author:DavisLisaL
,
pubmed-author:FlahertyKeith TKT
,
pubmed-author:GallagherMaryannM
,
pubmed-author:GiantonioBruceB
,
pubmed-author:O'DwyerPeter JPJ
,
pubmed-author:RosenMarkM
,
pubmed-author:SchnallMitchellM
,
pubmed-author:StevensonJames PJP
,
pubmed-author:SunWeijingW
,
pubmed-author:VaughnDavidD
,
pubmed-author:ZimmerRossR
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1527-33
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15746056-Adult
,
pubmed-meshheading:15746056-Aged
,
pubmed-meshheading:15746056-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:15746056-Area Under Curve
,
pubmed-meshheading:15746056-Carboplatin
,
pubmed-meshheading:15746056-Dose-Response Relationship, Drug
,
pubmed-meshheading:15746056-Drug Interactions
,
pubmed-meshheading:15746056-Female
,
pubmed-meshheading:15746056-Humans
,
pubmed-meshheading:15746056-Infusions, Intravenous
,
pubmed-meshheading:15746056-Male
,
pubmed-meshheading:15746056-Middle Aged
,
pubmed-meshheading:15746056-Nausea
,
pubmed-meshheading:15746056-Neoplasms
,
pubmed-meshheading:15746056-Neutropenia
,
pubmed-meshheading:15746056-Stilbenes
,
pubmed-meshheading:15746056-Thrombocytopenia
,
pubmed-meshheading:15746056-Treatment Outcome
,
pubmed-meshheading:15746056-Vomiting
pubmed:year
2005
pubmed:articleTitle
Phase I trial of combretastatin a-4 phosphate with carboplatin.
pubmed:affiliation
University of Pennsylvania Cancer Center, University of the Sciences in Philadelphia, Philadelphia, PA 19104, USA. bilenker@uphs.upenn.edu
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, Non-U.S. Gov't
,
Clinical Trial, Phase I